These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2. Moore SW, Appfelstaedt J, Zaahl MG. J Pediatr Surg; 2007 Feb 27; 42(2):326-32. PubMed ID: 17270543 [Abstract] [Full Text] [Related]
10. Medullary thyroid carcinoma: state of the art. Favia G, Iacobone M. G Chir; 2005 Feb 27; 26(11-12):405-9. PubMed ID: 16472416 [Abstract] [Full Text] [Related]
12. RET mutation status in medullary thyroid cancer(MTC) patients and the significance of genetic screening for mutations in their immediate relatives--a preliminary report. Menon MM, Simha MR. Indian J Pathol Microbiol; 2005 Apr 27; 48(2):161-5. PubMed ID: 16758654 [Abstract] [Full Text] [Related]
19. MIBG for diagnosis and therapy of medullary thyroid carcinoma: is there still a role? Castellani MR, Seregni E, Maccauro M, Chiesa C, Aliberti G, Orunesu E, Bombardieri E. Q J Nucl Med Mol Imaging; 2008 Dec 27; 52(4):430-40. PubMed ID: 19088696 [Abstract] [Full Text] [Related]
20. Long term prognosis of medullary thyroid carcinoma in 39 patients. Voutilainen PE, Multanen M, Haapiainen RK, Haglund CH, Sane T, Sivula AH. Ann Chir Gynaecol; 2000 Dec 27; 89(4):292-7. PubMed ID: 11204961 [Abstract] [Full Text] [Related] Page: [Next] [New Search]